About XVIVO

XVIVO is a medical technology company firmly rooted within medical science with more than 20 years of experience in the transplantation area.

XVIVO

We empower transplant teams to save more lives

XVIVO is a medical technology company with headquarter in Gothenburg, Sweden, a production site in Lund, Sweden and office in Denver, USA. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 20 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.

Vision

Our vision is that nobody should have to die waiting for an organ.

Mission

With our highly dedicated multi-disciplinary team we work together with transplant teams to give more patients a new life. Providing our customers with innovative clinically proven solutions and systems optimized for lung transplantation we work towards the goal of increasing the availability of acceptable donor organs and survival of patients awaiting transplantation.

Our solutions and system for EVLP are the first FDA approved* products to be used for EVLP on marginal donor lungs.

We are committed to provide our customers with solutions and systems that can:

  • Improve the transplant process outcome
  • Facilitate the work for the transplant team
  • Enhance the long-term outcomes and quality of life of the transplant recipient

XVIVO - Sharing the same vision

More than 20 years ago our founder, Dr Magnus Nilsson had a vision that nobody should die waiting for a new organ. Driven by his vision and with his interest in medical science he started collaboration with centers world-wide to make the vision come true. All of us working in the company share the vision and work dedicated to support transplant teams world-wide in their important and challenging work. Since the start, new committed employees and distributors have joined the company´s mission to developing innovative products and solutions that will ultimately lead to that nobody should have to die waiting for a transplant. With our highly dedicated multi-disciplinary team we work together with transplant teams to give more patients a chance to new life.

*In the US, this device is indicated for use in flushing and temporary continuous normothermic machine perfusion of initially unacceptable excised donor lungs during which time the ex vivo function of the lungs can be reassessed for transplantation.